Ventas, Inc. $VTR Shares Bought by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd lifted its holdings in shares of Ventas, Inc. (NYSE:VTR) by 6.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 158,651 shares of the real estate investment trust’s stock after buying an additional 9,240 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Ventas were worth $11,104,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Aberdeen Group plc raised its stake in shares of Ventas by 2.5% during the 2nd quarter. Aberdeen Group plc now owns 1,460,098 shares of the real estate investment trust’s stock worth $90,409,000 after buying an additional 35,965 shares during the last quarter. Investment Management Corp of Ontario raised its position in Ventas by 1,019.0% during the second quarter. Investment Management Corp of Ontario now owns 133,061 shares of the real estate investment trust’s stock worth $8,403,000 after acquiring an additional 121,170 shares during the last quarter. SCS Capital Management LLC acquired a new position in Ventas during the second quarter worth about $13,788,000. Hudson Bay Capital Management LP purchased a new stake in shares of Ventas in the second quarter valued at about $17,568,000. Finally, AXA S.A. grew its position in shares of Ventas by 58.8% in the second quarter. AXA S.A. now owns 333,388 shares of the real estate investment trust’s stock valued at $21,053,000 after purchasing an additional 123,395 shares during the last quarter. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CEO Peter J. Bulgarelli sold 2,229 shares of the business’s stock in a transaction that occurred on Wednesday, November 19th. The shares were sold at an average price of $80.08, for a total value of $178,498.32. Following the completion of the sale, the chief executive officer directly owned 106,488 shares in the company, valued at approximately $8,527,559.04. The trade was a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Robert F. Probst sold 29,930 shares of the company’s stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the transaction, the chief financial officer directly owned 138,434 shares of the company’s stock, valued at $10,694,026.50. This trade represents a 17.78% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 713,520 shares of company stock valued at $52,788,577. Insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. Weiss Ratings upgraded Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Jefferies Financial Group reissued a “buy” rating and issued a $93.00 price target on shares of Ventas in a report on Monday, December 15th. Wells Fargo & Company upped their price objective on Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. UBS Group assumed coverage on Ventas in a research report on Friday, September 19th. They set a “neutral” rating and a $73.00 price objective for the company. Finally, Citigroup upped their target price on shares of Ventas from $80.00 to $88.00 and gave the company a “buy” rating in a report on Tuesday, November 11th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Ventas presently has an average rating of “Moderate Buy” and an average price target of $80.65.

Ventas Price Performance

VTR stock opened at $74.90 on Friday. The stock has a market capitalization of $35.18 billion, a price-to-earnings ratio of 144.05, a price-to-earnings-growth ratio of 1.85 and a beta of 0.78. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 1.01. Ventas, Inc. has a 52-week low of $56.97 and a 52-week high of $81.89. The stock’s fifty day simple moving average is $78.25 and its 200-day simple moving average is $71.36.

Ventas (NYSE:VTR) last released its earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.01. Ventas had a return on equity of 2.05% and a net margin of 4.28%.The firm had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same period in the prior year, the business posted $0.80 earnings per share. The firm’s revenue for the quarter was up 20.5% compared to the same quarter last year. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. Equities research analysts expect that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st will be issued a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Wednesday, December 31st. Ventas’s dividend payout ratio is presently 369.23%.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.